Molecular Genetics of Cardiac Arrhythmias

Cordula M Wolf, Children's Hospital Boston, Boston, MA, USA
Charles I Berul, Children's National Medical Center, Washington, DC, USA

Published online: April 2010

DOI: 10.1002/9780470015902.a0022491

Abstract

Knowledge derived from human genetics and from studies in animal models has led to the discovery of multiple molecular defects underlying inherited arrhythmias and cardiac conduction system diseases in structurally altered or normal hearts.

Minor disturbances at the molecular and cellular levels can initiate severe rhythm abnormalities. Some congenital heart diseases and cardiomyopathies carry a higher risk for conduction disturbances or arrhythmias. In the structurally normal heart, inherited cardiac arrhythmias or conduction system disease are most often primary electrical diseases. The underlying molecular defect in those disorders, also termed ion channelopathies, typically involves genes that encode ion channels, responsible for maintaining intracellular and extracellular electrolyte balance.

Advances in molecular biology and genetics facilitate the identification of factors that may predispose an individual with or without structural heart disease to arrhythmias or sudden death. Taking those discoveries into clinical practice improves risk stratification and allows potential identification of new therapeutic targets.

Key Concepts:

  • Sudden unexpected cardiac death in the pediatric population is a devastating event with an incidence of approximately 1–6 in 100 000 per year and in some cases is the first presentation of a previously undiagnosed disorder.

  • Inherited arrhythmias and cardiac conduction system disease frequently occur in pediatric patients with congenital heart disease but can also be associated with a structurally normal heart.

  • Mutations in genes encoding for cytoskeletal proteins, sarcomeric proteins and ion channels are responsible for the majority of inherited arrhythmias associated with the structurally normal or abnormal heart.

  • Identifying the molecular basis of congenital arrhythmias optimises patient screening, risk stratification and allows genotype‐directed therapies of patients at risk for sudden cardiac death.

Keywords: arrhythmias; cardiac conduction system disease; congenital heart disease; molecular basis; long QT syndrome; channelopathies; electrophysiology; cardiomyopathy

Figure 1.

Anatomy of the cardiac conduction system. Four chamber view of the heart in a vertical section. The (SA) node is located in the upper right atrium between the venous inflow tract and the crista terminalis. The (AV) node is identified in the crux of the heart, near the anterior component of the tricuspid annulus. The His bundle is the proximal component of the central conduction system leaving the AV node and penetrating through the annulus fibrosis. The bundle branches emanate from the His bundle to provide specialised conduction tracts through both ventricles. SVC, superior vena cava and IVC, inferior vena cava.
Figure 2.

Action potential in myocytes. Shown is the action potential shape of atrial and ventricular myocytes in (a) (Wolf CM and Berul CL (2008) Molecular mechanisms of inherited arrhythmias. Current Genomics 9: 160–168.) and of nodal conduction system cells in (b) (upper part), the relevant ion currents crossing the cell membrane (middle part) and the corresponding electrocardiographic ventricular activity (lower part). The action potential of atrial and ventricular myocytes (a) consists of four phases, characteristically of a long plateau phase (3) and a stable resting phase (4). The action potential of nodal conduction system cells (b) differs in phases 4 and 0 in that there is a slow upstroke phase replacing the stable resting phase 4 which allows the cell to spontaneously depolarise. The initial upstroke in phase 0 is caused by calcium instead of sodium influx. The cardiac delayed rectifier current (IK) is a major determinant of phase 3 of the cardiac action potential. It comprises three independent components: Ikur (ultrarapid), Ikr (rapid) and a catecholamine‐sensitive component IKs (slow). Other currents, such as the plateau delayed rectifier K+ current (Ik2p) and the inward rectifier K+ current (IK1), also contribute to repolarisation. The conductance of inward rectifying K+ channels (IK1) is highest near the equilibrium potential for K+. The transient outward potassium current (Ito) is responsible for the initial rapid phase of action potential repolarisation, discernible as a notch preceding the plateau phase. The acetylcholine‐activated current IKACh is mainly found in SA and AV nodal cells and is directly activated by the Gβγ subunit of the G protein, when acetylcholine binds to muscarinic M2 receptors. The adenosine triphosphate‐sensitive current IKATP is inhibited by physiological intracellular ATP levels and thus couples the cell metabolism to the membrane potential. IATP channels function to stabilise resting potential and shorten action potentials. INa, sodium current; ICa,L, L‐type calcium current; INa,Ca, sodium/calcium exchanger; ICa,T, T‐type calcium current; If and pacemaker current. (b) Reproduced from Wolf CM and Berul CI (2006) Inherited conduction system abnormalities – one group of diseases, many genes. Journal of Cardiocascular Electrophysiology 17(4): 446–455.
close

References

Alings M and Wilde A (1999) Brugada syndrome: clinical data and suggested pathophysiological mechanism. Circulation 99: 666–673.

Antzelevitch C (2001a) The Brugada syndrome: diagnostic criteria and cellular mechanisms. European Heart Journal 22: 356–363.

Antzelevitch C (2001b) The Brugada syndrome: ionic basis and arrhythmia mechanisms. Journal of Cardiovascular Electrophysiology 12: 268–272.

Arad M, Moskowitz IP, Patel VV et al. (2003) Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff‐Parkinson‐White syndrome in glycogen storage cardiomyopathy. Circulation 107: 2850–2856.

Arking DE, Pfeufer A, Post W et al. (2006) A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nature Genetics 38: 644–651.

Barhanin J, Lesage F, Guillemare E et al. (1996) K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 384: 78–80.

Basson CT, Huang T, Lin RC et al. (1999) Different TBX5 interactions in heart and limb defined by Holt‐Oram syndrome mutations. Proceedings of the National Academy of Sciences of the USA 96: 2919–2924.

Berul CI, Maguire CT, Aronovitz MJ et al. (1999) DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. Journal of Clinical Investigation 103: R1–R7.

Bhuiyan ZA, Hamdan MA, Shamsi ET et al. (2007) A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14‐p22. Journal of Cardiovascular Electrophysiology 18: 1060–1066.

Bonne G, Di Barletta MR, Varnous S et al. (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery‐Dreifuss muscular dystrophy. Nature Genetics 21: 285–288.

Brugada P and Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. Journal of American College of Cardiology 20: 1391–1396.

Bruneau BG, Nemer G, Schmitt JP et al. (2001) A murine model of Holt‐Oram syndrome defines roles of the T‐box transcription factor Tbx5 in cardiogenesis and disease. Cell 106: 709–721.

Brugada R, Tapscott T, Czernuszewicz GZ et al. (1997) Identification of a genetic locus for familial atrial fibrillation. New England Journal of Medicine 336: 905–911.

Calaghan SC, Belus A and White E (2003) Do stretch‐induced changes in intracellular calcium modify the electrical activity of cardiac muscle? Progress in Biophysics and Molecular Biology 82: 81–95.

Chen L, Marquardt ML, Tester DJ et al. (2007) Mutation of an A‐kinase‐anchoring protein causes long‐QT syndrome. Proceedings of the National Academy of Sciences of the USA 104: 20990–20995.

Durocher D, Charron F, Warren R, Schwartz RJ and Nemer M (1997) The cardiac transcription factors Nkx2‐5 and GATA‐4 are mutual cofactors. EMBO Journal 16: 5687–5696.

Ebralidze A, Wang Y, Petkova V, Ebralidse K and Junghans RP (2004) RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 303: 383–387.

Fatkin D, MacRae C, Sasaki T et al. (1999) Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction‐system disease. New England Journal of Medicine 341: 1715–1724.

Gollob MH, Green MS, Tang AS et al. (2001) Identification of a gene responsible for familial Wolff‐Parkinson‐White syndrome. New England Journal of Medicine 344: 1823–1831.

Gussak I, Brugada P, Brugada J et al. (2000) Idiopathic short QT interval: a new clinical syndrome? Cardiology 94: 99–102.

Hedley PL, Jorgensen P, Schlamowitz S et al. (2009) The genetic basis of Brugada syndrome: a mutation update. Human Mutation 30: 1256–1266.

Herfst LJ, Rook MB and Jongsma HJ (2004) Trafficking and functional expression of cardiac Na+ channels. Journal of Molecular Cell Cardiology 36: 185–193.

Hutchison CJ, Alvarez‐Reyes M and Vaughan OA (2001) Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue‐specific disease phenotypes? Journal of Cell Sciences 114: 9–19.

Kao WH, Arking DE, Post W et al. (2009) Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community‐based populations. Circulation 119: 940–951.

Knollmann BC and Roden DM (2008) A genetic framework for improving arrhythmia therapy. Nature 451: 929–936.

Kuo HC, Cheng CF, Clark RB et al. (2001) A defect in the Kv channel‐interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 107: 801–813.

Lahat H, Pras E, Olender T et al. (2001) A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine‐induced polymorphic ventricular tachycardia in Bedouin families from Israel. American Journal of Human Genetics 69: 1378–1384.

Leenhardt A, Lucet V, Denjoy I et al. (1995) Catecholaminergic polymorphic ventricular tachycardia in children. A 7‐year follow‐up of 21 patients. Circulation 91: 1512–1519.

Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287: 1308–1320.

Medeiros‐Domingo A, Kaku T, Tester DJ et al. (2007) SCN4B‐encoded sodium channel beta4 subunit in congenital long‐QT syndrome. Circulation 116: 134–142.

Mohler PJ, Schott JJ, Gramolini AO et al. (2003) Ankyrin‐B mutation causes type 4 long‐QT cardiac arrhythmia and sudden cardiac death. Nature 421: 634–639.

Morita H, Wu J and Zipes DP (2008) The QT syndromes: long and short. Lancet 372: 750–763.

Muchir A, Bonne G, van der Kooi AJ et al. (2000) Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Human Molecular Genetics 9: 1453–1459.

Napolitano C, Rivolta I and Priori SG (2003) Cardiac sodium channel diseases. Clinical Chemistry and Laboratory Medicine 41: 439–444.

Nerbonne JM, Nichols CG, Schwarz TL and Escande D (2001) Genetic manipulation of cardiac K(+) channel function in mice: what have we learned, and where do we go from here? Circulation Research 89: 944–956.

Newton‐Cheh C, Eijgelsheim M, Rice KM et al. (2009) Common variants at ten loci influence QT interval duration in the QTGEN Study. Nature Genetics 41: 399–406.

Plaster NM, Tawil R, Tristani‐Firouzi M et al. (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105: 511–519.

Pogwizd SM (1995) Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits. Circulation 92: 1034–1048.

Polekhina G, Gupta A, Michell BJ et al. (2003) AMPK beta subunit targets metabolic stress sensing to glycogen. Current Biology 13: 867–871.

Priori SG, Napolitano C, Gasparini M et al. (2002) Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105: 1342–1347.

Priori SG, Napolitano C, Tiso N et al. (2001) Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103: 196–200.

Probst V, Kyndt F, Potet F et al. (2003) Haploinsufficiency in combination with aging causes SCN5A‐linked hereditary Lenegre disease. Journal of American College of Cardiology 41: 643–652.

Schimpf R, Bauersfeld U, Gaita F and Wolpert C (2005) Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter‐defibrillator treatment for primary prophylaxis. Heart Rhythm 2: 416–417.

Schott JJ, Alshinawi C, Kyndt F et al. (1999) Cardiac conduction defects associate with mutations in SCN5A. Nature Genetics 23: 20–21.

Schott JJ, Benson DW, Basson CT et al. (1998) Congenital heart disease caused by mutations in the transcription factor NKX2‐5. Science 281: 108–111.

Schulze‐Bahr E, Neu A, Friederich P et al. (2003) Pacemaker channel dysfunction in a patient with sinus node disease. Journal of Clinical Investigation 111: 1537–1545.

Schwartz PJ, Priori SG, Spazzolini C et al. (2001) Genotype‐phenotype correlation in the long‐QT syndrome: gene‐specific triggers for life‐threatening arrhythmias. Circulation 103: 89–95.

Splawski I, Shen J, Timothy KW et al. (2000) Spectrum of mutations in long‐QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102: 1178–1185.

Splawski I, Timothy KW, Sharpe LM et al. (2004) Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119: 19–31.

Swynghedauw B (1999) Molecular mechanisms of myocardial remodeling. Physiologcal Review 79: 215–262.

Thiene G, Nava A, Corrado D, Rossi L and Pennelli N (1988) Right ventricular cardiomyopathy and sudden death in young people. New England Journal of Medicine 318: 129–133.

Towbin JA and Bowles NE (2002) The failing heart. Nature 415: 227–233.

Tsai CT, Lai LP, Hwang JJ, Lin JL and Chiang FT (2008) Molecular genetics of atrial fibrillation. Journal of American College of Cardiology 52: 241–250.

Ueda K, Nakamura K, Hayashi T et al. (2004) Functional characterization of a trafficking‐defective HCN4 mutation, D553N, associated with cardiac arrhythmia. Journal of Biological Chemistry 279: 27194–27198.

Ueda K, Valdivia C, Medeiros‐Domingo A et al. (2008) Syntrophin mutation associated with long QT syndrome through activation of the nNOS‐SCN5A macromolecular complex. Proceedings of the National Academy of Sciences of the USA 105: 9355–9360.

Vatta M, Ackerman MJ, Ye B et al. (2006) Mutant caveolin‐3 induces persistent late sodium current and is associated with long‐QT syndrome. Circulation 114: 2104–2112.

Vincent GM, Timothy KW, Leppert M and Keating M (1992) The spectrum of symptoms and QT intervals in carriers of the gene for the long‐QT syndrome. New England Journal of Medicine 327: 846–852.

Wolf CM, Arad M, Ahmad F et al. (2008a) Reversibility of PRKAG2 glycogen‐storage cardiomyopathy and electrophysiological manifestations. Circulation 117: 144–154.

Wolf CM, Moskowitz IP, Arno S et al. (2005) Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia. Proceedings of the National Academy of Sciences of the USA 102: 18123–18128.

Wolf CM, Wang L, Alcalai R et al. (2008b) Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis‐triggered cardiac conduction system disease. Journal of Molecular Cell Cardiology 44: 293–303.

Wu TJ, Ong JJ, Hwang C et al. (1998) Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. Journal of American College of Cardiology 32: 187–196.

Further Reading

Arad M, Maron BJ, Gorham JM et al. (2005) Glycogen storage diseases presenting as hypertrophic cardiomyopathy. New England Journal of Medicine 352: 362–372.

Chen Q, Kirsch GE, Zhang D et al. (1998) Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392: 293–296.

Keating MT and Sanguinetti MC (2001) Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104: 569–580.

Seidman JG and Seidman C (2001) The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104: 557–567.

Shah M, Akar FG and Tomaselli GF (2005) Molecular basis of arrhythmias. Circulation 112: 2517–2529.

Related Sub-Topics:

Linkage Analysis | Action Potential | Ion Channels | Molecular Genetics of Common and Complex Disease
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

Article Title: Molecular Genetics of Cardiac Arrhythmias
 
How to Cite close
Wolf, Cordula M, and Berul, Charles I(Apr 2010) Molecular Genetics of Cardiac Arrhythmias. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0022491]